Princeton Capital Management Inc’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-34,825
| Closed | -$177K | – | 78 |
|
|
2016
Q2 | $177K | Hold |
34,825
| – | – | 0.12% | 69 |
|
|
2016
Q1 | $199K | Hold |
34,825
| – | – | 0.14% | 65 |
|
|
2015
Q4 | $361K | Hold |
34,825
| – | – | 0.25% | 52 |
|
|
2015
Q3 | $643K | Hold |
34,825
| – | – | 0.39% | 45 |
|
|
2015
Q2 | $678K | Hold |
34,825
| – | – | 0.36% | 46 |
|
|
2015
Q1 | $612K | Sell |
34,825
-1,300
| -4% | -$22.8K | 0.31% | 47 |
|
|
2014
Q4 | $578K | Buy |
36,125
+300
| +0.8% | +$4.8K | 0.32% | 50 |
|
|
2014
Q3 | $451K | Hold |
35,825
| – | – | 0.29% | 55 |
|
|
2014
Q2 | $560K | Buy |
35,825
+8,050
| +29% | +$126K | 0.39% | 56 |
|
|
2014
Q1 | $365K | Buy |
27,775
+1,400
| +5% | +$18.4K | 0.26% | 63 |
|
|
2013
Q4 | $424K | Buy |
26,375
+500
| +2% | +$8.04K | 0.34% | 59 |
|
|
2013
Q3 | $431K | Buy |
25,875
+5,000
| +24% | +$83.3K | 0.39% | 57 |
|
|
2013
Q2 | $210K | Buy |
+20,875
| New | +$210K | 0.2% | 64 |
|